Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Tuesday, November 24, 2009, 9:04PM ET - U.S. Markets Closed. Dow Down 0.16% Nasdaq Down 0.31%
Aastrom Biosciences, Inc. (ASTM)At 3:59PM ET: 0.2933  Down 0.0147 (4.77%)  
MORE ON ASTM
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Aastrom Biosciences, Inc.
Dominos Farms Lobby K
24 Frank Lloyd Wright Drive
Ann Arbor, MI 48105
United States - Map
Phone: 734-930-5555
Fax: 734-665-0485
Web Site: http://www.aastrom.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:48

BUSINESS SUMMARY 
Aastrom Biosciences, Inc. engages in developing autologous cell products for the repair or regeneration of human tissue. Its proprietary tissue repair cell (TRC) technology involves the use of a patient's own cells to manufacture products to treat a range of chronic diseases and serious injuries. The company’s TRC-based products contain increased numbers of stem and early progenitor cells, produced from a small amount of bone marrow collected from the patient. Aastrom’s development activities are focused on applying TRC technology to cardiac and vascular tissue regeneration. It focuses on cardiovascular regeneration and is conducting a Phase II clinical trial with dilated cardiomyopathy patients (the IMPACT-DCM clinical trial) and a Phase IIb clinical trial with critical limb ischemia patients (the RESTORE-CLI clinical trial). The company was founded in 1989 and is headquartered in Ann Arbor, Michigan.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Aastrom Biosciences, Inc.


    CORPORATE GOVERNANCE 
    Aastrom Biosciences, Inc.'s Corporate Governance Quotient (CGQ®) as of 6-Nov-09 is better than 85% of CGQ Universe companies and 67.6% of Pharmaceuticals, Biotechnology & Life Sciences companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. George W. Dunbar Jr., 62
    Chief Exec. Officer, Pres, Chief Financial Officer, Principal Accounting Officer
    $ 375.00K $ 0
    Dr. Ronnda L. Bartel Ph.D., 50
    VP of Technical Operations
    N/A N/A
    Ms. Julie A. Caudill ,
    Corp. Sec. and Controller
    N/A N/A
    Kris M. Maly ,
    Sr. Director of Communications & Admin.
    N/A N/A
    Mr. Sheldon A. Schaffer Ph.D., 65
    VP of Corp. Devel. & Intellectual Property
    N/A N/A
    Dollar amounts are as of 31-Dec-09 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis